Search - tctmd.com

Displaying 561 - 580 of 874

Sort: Relevancy | Date

Presentation TCT 2017

TAVR in Moderate Aortic Stenosis + Heart Failure: Updates From the UNLOAD Trial

Presenter: Ariel Finkelstein, Ran Kornowski, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

Case #1 (With Discussion): Aortic Stenosis With Concomitant CAD

Presenter: William F. Fearon, Matthias Götberg, Gary S. Mintz, Evelyn S. Regar

November 01, 2017

Presentation TCT 2017

Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis!

Presenter: Gilles Dreyfus, Sanjay Kaul, Alfredo Trento

November 01, 2017

Presentation TCT 2017

Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis!

Presenter: Gilles Dreyfus, Sanjay Kaul, John G. Webb

November 01, 2017

Presentation TCT 2017

Concomitant Severe Aortic Stenosis and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

Presenter: A. Pieter Kappetein, Georg Nickenig, Joachim Schofer

November 01, 2017

Presentation TCT 2017

Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other

Presenter: Alfredo Trento, David J. Cohen

November 01, 2017

Presentation TCT 2017

Case Conclusion: A Patient With a Complex Distal Left Main Stenosis Case and Mild to Moderate Aortic Stenosis How I Treated

Presenter: James B. Hermiller Jr., John D. Puskas, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

Case Introduction: A Patient With a Complex Distal Left Main Stenosis Case and Mild to Moderate Aortic Stenosis

Presenter: James B. Hermiller Jr., John D. Puskas, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

Multimodality Imaging to Risk Stratify Patients With Aortic Stenosis

Presenter: Bernard Prendergast, Brian K. Whisenant, Victoria Delgado

November 01, 2017

Presentation TCT 2017

Asymptomatic Severe Aortic Stenosis: To Treat or to Watch?

Presenter: Bernard Prendergast, Brian K. Whisenant, Allan Schwartz

November 01, 2017

Presentation TCT 2017

Identifying the Futile Severe AS Patient - Who Shouldnt Be Treated With TAVR?

Presenter: Bernard Prendergast, Brian K. Whisenant, David J. Cohen

November 01, 2017

Presentation TCT 2017

Bio-Echocardiography to Monitor PVL during and after TAVR: The Case for Point-of-Care Von Willebrand Factor Testing

Presenter: Bernard Prendergast, Brian K. Whisenant, Eric Van Belle

November 01, 2017

Presentation TCT 2017

Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions

Presenter: Bernard Prendergast, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

Presenter: Jean-Claude Laborde, Eric Van Belle, Luca Baldetti, MD

October 31, 2017

Presentation TCT 2017

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Presenter: Jean-Claude Laborde, Eric Van Belle, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

TCT 31: Hybrid iFR-FFR Decision-Making Strategy in Coronary Revascularization of Patients With Severe Aortic Stenosis Undergoing TAVI

Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD

October 31, 2017

Presentation TCT 2017

TCT 38: Self-Expanding TAVR for Treatment of Aortic Insufficiency: An Analysis of the STS/ACC TVT Registry

Presenter: Jean-Claude Laborde, Eric Van Belle, Saif Anwaruddin

October 31, 2017

Presentation TCT 2017

TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD

October 31, 2017

Presentation TCT 2017

TCT 37: Sudden Cardiac Death in Patients With Severe Aortic Stenosis

Presenter: Jean-Claude Laborde, Eric Van Belle, Tomohiko Taniguchi, MD

October 31, 2017

Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen

October 31, 2017

Advertisement

TAVR in Moderate Aortic Stenosis + Heart Failure: Updates From the UNLOAD Trial

Case #1 (With Discussion): Aortic Stenosis With Concomitant CAD

Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis!

Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis!

Concomitant Severe Aortic Stenosis and Mitral Regurgitation: Is There a Role for Concurrent Transcatheter Therapy?

Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other

Case Conclusion: A Patient With a Complex Distal Left Main Stenosis Case and Mild to Moderate Aortic Stenosis How I Treated

Case Introduction: A Patient With a Complex Distal Left Main Stenosis Case and Mild to Moderate Aortic Stenosis

Multimodality Imaging to Risk Stratify Patients With Aortic Stenosis

Asymptomatic Severe Aortic Stenosis: To Treat or to Watch?

Identifying the Futile Severe AS Patient - Who Shouldnt Be Treated With TAVR?

Bio-Echocardiography to Monitor PVL during and after TAVR: The Case for Point-of-Care Von Willebrand Factor Testing

Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

TCT 31: Hybrid iFR-FFR Decision-Making Strategy in Coronary Revascularization of Patients With Severe Aortic Stenosis Undergoing TAVI

TCT 38: Self-Expanding TAVR for Treatment of Aortic Insufficiency: An Analysis of the STS/ACC TVT Registry

TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

TCT 37: Sudden Cardiac Death in Patients With Severe Aortic Stenosis

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content